|

COPD Clinical Trials in Mesa, AZ

15 recruiting studies within 50 miles

Phase
Trial Phase Dist.
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary DiseasePhase 3<1 mi
A Study to Evaluate Solrikitug in Participants With COPD (ZION)Phase 25 mi
Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3N/A5 mi
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)Phase 38 mi
Pulmonary Rehabilitation for Rural Patients With COPDN/A8 mi
SPIROMICS Study of Early COPD Progression (SOURCE)—8 mi
myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the HomeN/A8 mi
A Phase IIb Ensifentrine-glycopyrrolate Fixed-dose Combination Dose Ranging Study in Subjects With COPDPhase 214 mi
A Study to Evaluate the Long-Term Safety of Astegolimab in Participants With Chronic Obstructive Pulmonary Disease (COPD)Phase 314 mi
An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe EmphysemaN/A14 mi
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)Phase 314 mi
STRIVE Post-Market Registry Study—14 mi
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic PhenotypePhase 314 mi
A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary DiseasePhase 214 mi
A Study to Evaluate Astegolimab in Participants With Chronic Obstructive Pulmonary DiseasePhase 322 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.